Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opioid use disorder and dementia risk: evidence from observational and genetic analyses in diverse ancestry cohorts.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Cognition and future depression: associations with risk in those with and without a history of depression.

BMJ mental health·2026
Same author

Will Precision Medicine Still Require Neuropsychiatric Phenotypes?

Neurology·2026
Same author

Cannabis use, cognitive function and dementia risk in older adults: observational and genetic analyses.

BMJ mental health·2026
Same author

The Relationship Between Hippocampal Cerebrovascular Reactivity and Brain Structure in Older Age.

Human brain mapping·2026
Same author

Relationships between alcohol use and dementia: protocol for an observational study in the UK Clinical Practice Research Datalink.

BMJ open·2026
Same journal

Improving pain control in diabetic neuropathy.

The Practitioner·2017
Same journal

Tailor management to the patient with fibroids.

The Practitioner·2017
Same journal

Preventing stroke and assessing risk in women.

The Practitioner·2017
Same journal

Depression in adults linked to maltreatment in childhood.

The Practitioner·2017
Same journal

Early referral improves long-term outcomes in rheumatoid arthritis.

The Practitioner·2017
Same journal

Diagnosing and managing mild cognitive impairment.

The Practitioner·2017
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Normal cognitive decline or dementia?

Klaus P Ebmeier1

  • 1University of Oxford.

The Practitioner
|March 5, 2010
PubMed
Summary
This summary is machine-generated.

Cognitive abilities decline with age, but some factors like smoking and diabetes increase dementia risk. Lifestyle choices and medical interventions can impact cognitive health and dementia progression.

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

Related Experiment Videos

Last Updated: Jun 15, 2026

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
10:13

Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach

Published on: February 14, 2014

Area of Science:

  • Gerontology
  • Neuroscience
  • Public Health

Background:

  • Cognitive functions like speed and memory decline with age, while crystallized abilities remain stable.
  • Risk factors for accelerated cognitive decline include poor health, low education, inactivity, APOE E4 allele, and hypertension.
  • Dementia diagnosis requires objective cognitive impairment, memory deficits, additional cortical deficits, and functional decline.

Purpose of the Study:

  • To review factors influencing cognitive decline and dementia risk.
  • To assess the efficacy of various interventions and lifestyle choices on cognitive health.
  • To differentiate between dementia and depressive symptoms presenting with cognitive impairment.

Main Methods:

  • Literature review of factors affecting cognitive aging and dementia.
  • Analysis of epidemiological data and clinical studies on risk factors and interventions.
  • Comparison of diagnostic criteria for dementia and depression-induced cognitive changes.

Main Results:

  • Smoking and diabetes increase dementia risk; smoking cessation is beneficial, but diabetes control shows no measurable effect.
  • Moderate alcohol consumption may ameliorate cognitive decline.
  • HRT, DHEA, BP lowering (without prior cerebrovascular disease), statins, vitamin B6, and procaine are not helpful; evidence is insufficient for exercise, diabetes treatment, omega-3s, B vitamins, antioxidants, or ginkgo biloba.

Conclusions:

  • Cognitive aging is multifactorial, influenced by genetics, lifestyle, and health status.
  • Interventions like smoking cessation show promise, while others lack sufficient evidence for efficacy.
  • Accurate diagnosis is crucial, differentiating dementia from depression, with distinct referral pathways for memory clinics and mental health teams.